Sierra Leone vs Trinidad and Tobago: Number of clinical trials
Sierra Leone
2 trials
in 2024
Trinidad and Tobago
2 trials
in 2023
Sierra Leone rank
108th
Trinidad and Tobago rank
108th
Number of clinical trials over time
- Sierra Leone
- Trinidad and Tobago
How they compare
Sierra Leone currently reports 2 trials against 2 trials in Trinidad and Tobago, a difference of 0 trials.
The two have swapped places 6 times across 8 shared years of data; in 2004 it was Trinidad and Tobago ahead.
Sierra Leone ranks 108th and Trinidad and Tobago ranks 108th of 153 countries.
Sierra Leone has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sierra Leone | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1 trials | 1 trials | 0 trials | — |
| 2010s | 3.33 trials | 1.33 trials | 2 trials | Sierra Leone |
| 2020s | 2.25 trials | 2.25 trials | 0 trials | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Sierra Leone or Trinidad and Tobago?
- Sierra Leone, at 2 trials against 2 trials in Trinidad and Tobago as of 2024.
- What is the difference in number of clinical trials between Sierra Leone and Trinidad and Tobago?
- 0 trials, with Sierra Leone ahead.
- How many years of comparable data are there for Sierra Leone and Trinidad and Tobago?
- 8 years are reported by both, from 2004 to 2023.
- How do Sierra Leone and Trinidad and Tobago rank globally for number of clinical trials?
- Sierra Leone ranks 108th and Trinidad and Tobago ranks 108th of 153 countries.
- Where does this data come from?
- ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.